These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19303982)

  • 1. Suppressing the suppressor: Role of immunosuppressive regulatory T cells in cancer surgery.
    Baumgartner JM; McCarter MD
    Surgery; 2009 Apr; 145(4):345-50. PubMed ID: 19303982
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of immune escape of cancer and its regulation.
    Morita R; Hirohashi Y; Torigoe T
    Rinsho Ketsueki; 2009 May; 50(5):375-80. PubMed ID: 19483397
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancer.
    Chouaib S; Meslin F; Thiery J; Mami-Chouaib F
    Clin Immunol; 2009 Jan; 130(1):34-40. PubMed ID: 19013109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic management of cancer].
    Unsgård G
    Tidsskr Nor Laegeforen; 1981 Aug; 101(24):1322-6. PubMed ID: 6457419
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer and environment.
    Cavallo G
    G Batteriol Virol Immunol; 1979; 71(1-6):26-33. PubMed ID: 158557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of T regulatory (Treg) cells in cancer immunity; management of HIV-associated inflammation; and characterization of the homing pathways undertaken by mesenchymal stromal cells. Editorial.
    Bot A
    Int Rev Immunol; 2010 Oct; 29(5):459-60. PubMed ID: 20839910
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigen-specific suppressor ("blocking") factors in tumor immunity.
    Hellström KE; Hellström I; Nelson K
    Biomembranes; 1983; 11():365-88. PubMed ID: 6219721
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Meregalli S; Porro G; Rovelli F; Vigorè L; Tisi E; D'Amico G
    Anticancer Res; 2009 May; 29(5):1847-52. PubMed ID: 19443415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. About human tumor antigens to be used in immunotherapy.
    Lucas S; Coulie PG
    Semin Immunol; 2008 Oct; 20(5):301-7. PubMed ID: 18395462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanisms of tumor and immune system interaction].
    Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
    Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Suppressor T cells at the root of tumor escape].
    Med Sci (Paris); 2005 Jan; 21(1):31. PubMed ID: 15712381
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
    Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
    J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive influences in the immune response to cancer.
    Bronte V; Mocellin S
    J Immunother; 2009 Jan; 32(1):1-11. PubMed ID: 19307988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses.
    de Souza AP; Bonorino C
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1317-32. PubMed ID: 19761435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor cell function in solid tumor cancer patients.
    Von Roenn J; Harris JE; Braun DP
    J Clin Oncol; 1987 Jan; 5(1):150-9. PubMed ID: 2949064
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
    Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escape of tumours from immunological destruction.
    Kumar RK; Penny R
    Pathology; 1982 Apr; 14(2):173-9. PubMed ID: 6212902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of suppressor cells in the low effectiveness of adoptive immunotherapy for human cancers.
    Koyama S
    Intern Med; 1993 May; 32(5):357-8. PubMed ID: 8400492
    [No Abstract]   [Full Text] [Related]  

  • 19. Revisiting the prognostic value of regulatory T cells in patients with cancer.
    Badoual C; Hans S; Fridman WH; Brasnu D; Erdman S; Tartour E
    J Clin Oncol; 2009 Jul; 27(19):e5-6; author reply e7. PubMed ID: 19470910
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunotherapy of human tumors].
    Sinkovics J
    Orv Hetil; 1993 Jan; 134(2):101. PubMed ID: 8419882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.